Evidence Based Medication Safety Innovation unit (CSA732)

Online

Introduction

Evidence based Medication Safety Innovation will help you identify and analyse medication-safety issues encountered in a variety of clinical settings. 

You will initially learn about and appraise existing issues and interventions that attempt to improve the Quality Use of Medicines or address medication-safety issues. You will then devise innovative ideas to overcome these issues and develop evidence-based solutions that could be implemented in the real world.

Particular emphasis is placed on the combined skills of practice-based mitigation of medication-safety risks, while using research skills and knowledge, to intervene in identified problematic areas in an evidence-based manner.

Summary

Unit name	Evidence Based Medication Safety Innovation
Unit code	CSA732
Credit points	12.5
College/School	Health School of Pharmacy and Pharmacology
Discipline	Pharmacy
Coordinator	Doctor Woldesellassie Bezabhe
Delivered By	University of Tasmania
Level	Postgraduate

Availability

Location	Study period	Attendance options		Available to
Online	Semester 2

Note

Please check that your computer meets the minimum System Requirements if you are attending via Distance/Off-Campus.

Units are offered in attending mode unless otherwise indicated (that is attendance is required at the campus identified). A unit identified as offered by distance, that is there is no requirement for attendance, is identified with a nominal enrolment campus. A unit offered to both attending students and by distance from the same campus is identified as having both modes of study.

Key Dates

Study Period	Start date	Census date	WW date	End date
Semester 2	5/7/2026	27/7/2026	30/8/2026	24/10/2026

* The Final WW Date is the final date from which you can withdraw from the unit without academic penalty, however you will still incur a financial liability (refer to How do I withdraw from a unit? for more information).

Unit census dates currently displaying for 2026 are indicative and subject to change. Finalised census dates for 2026 will be available from the 1st October 2025. Note census date cutoff is 11.59pm AEST (AEDT during October to March).

About Census Dates

Learning Outcomes

• Critically evaluate factors contributing to medication-related incidents.
• Formulate strategies to reduce medication-related harm in clinical practice setting.
• Critically analyse approaches to improving medication safety.

Fee Information

Field of Education	Commencing Student Contribution 1,3	Grandfathered Student Contribution 1,3	Approved Pathway Course Student Contribution 2,3	Domestic Full Fee 4
060501	$1,192.00	$1,192.00	not applicable	$2,862.00

• Available as a Commonwealth Supported Place
• HECS-HELP is available on this unit, depending on your eligibility³
• FEE-HELP is available on this unit, depending on your eligibility⁴

¹ Please refer to more information on student contribution amounts.
² Please refer to more information on eligibility and Approved Pathway courses.
³ Please refer to more information on eligibility for HECS-HELP.
⁴ Please refer to more information on eligibility for FEE-HELP.

If you have any questions in relation to the fees, please contact UniConnect or more information is available on StudyAssist.

Please note: international students should refer to What is an indicative Fee? to get an indicative course cost.

Requisites

Prerequisites

CSA731 Evidence Based Pharmacotherapeutic Practice

Teaching

Teaching Pattern	Independent Learning (online modules) – 10hrs per week
Assessment	Written Assessment - Medication Safety Scenario (30%)|Written Assessment - QUM Evaluation (30%)|The Pitch (40%)
Timetable	View the lecture timetable | View the full unit timetable

Textbooks

Required	Required Readings will be provided by your Unit Coordinator.
Recommended	Recommended Readings will be provided by your Unit Coordinator via the Reading List link in MyLO, or the unit Reading List on the University Library website.

The University reserves the right to amend or remove courses and unit availabilities, as appropriate.